In this issue:
Intercalated chemotherapy/erolotinib benefits NSCLC
Carboplatin ± pemetrexed in NSCLC and ECOP PS 2
PARAMOUNT: final overall survival results
Maintenance bevacizumab ± pemetrexed in nonsquamous NSCLC
Incorporate BVI into the TNM staging system?
Resection vs stereotactic radiosurgery in NSCLC
Cost-effectiveness of SBRT vs lobectomy in stage I NSCLC
Air pollution contributes to lung cancer
Continuation of an EGFR TKI after progression
Bronchial colonisation: a negative prognostic marker in NSCLC?
Please login below to download this issue (PDF)